Your browser doesn't support javascript.
loading
[Retracted] miRNA­490­3p promotes the metastatic progression of invasive ductal carcinoma.
Lu, Ning; Zhang, Mei; Lu, Lu; Liu, Yan-Zhao; Zhang, Hai-Hong; Liu, Xiao-Dong.
Afiliação
  • Lu N; Department of Breast Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianj
  • Zhang M; Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
  • Lu L; Department of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China.
  • Liu YZ; Department of Medicine, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.
  • Zhang HH; Department of Human Resources, Tianjin Hospital, Tianjin 300211, P.R. China.
  • Liu XD; Department of Breast Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianj
Oncol Rep ; 52(5)2024 Nov.
Article em En | MEDLINE | ID: mdl-39219256
ABSTRACT
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Fig. 2D, the cell migration and invasion assay data in Fig. 3C, the mouse imaging pictures in Fig. 4C and D, and the H&E­stained images in Fig. 4E and F were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had already been submitted or published elsewhere prior to the submission of this paper to Oncology Reports. Given that the abovementioned data had already apparently been submitted or published prior to the receipt of this paper at Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 45 706­716, 2021; DOI 10.3892/or.2020.7880].
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Rep Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article
...